Journal profile · Allergy
CLINICAL AND EXPERIMENTAL ALLERGY
ISSN 0954-7894 · eISSN 1365-2222 · Wiley-Blackwell Publishing Ltd · ENGLAND · Monthly · Founded 1989
CLINICAL AND EXPERIMENTAL ALLERGY: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 5.01; hybrid open access; APC about USD 4,760; median 88 days to acceptance (90 articles, last 24 months); community-reported acceptance: fairly hard; 260 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
CLINICAL AND EXPERIMENTAL ALLERGY is published by Wiley-Blackwell Publishing Ltd and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Asthma and respiratory diseases, Allergic Rhinitis and Sensitization and Food Allergy and Anaphylaxis Research, together about 52.8% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Clinical & Experimental Allergy strikes an excellent balance between clinical and scientific articles and carries regular reviews and editorials written by leading authorities in their field. In response to the increasing number of quality submissions, since 1996 the journals size has increased by over 30%. Clinical & Experimental Allergy is essential reading for allergy practitioners and research scientists with an interest in allergic diseases and mechanisms. Truly international in appeal, Clinical & Experimental Allergy publishes clinical and experimental observations in disease in all fields of medicine in which allergic hypersensitivity plays a part.
Source: LetPub
Research area (LetPub): Allergy
Main research topics OpenAlex counts of recent articles; shares are approximate
- Asthma and respiratory diseasesMedicine23.1%
- Allergic Rhinitis and SensitizationMedicine17.9%
- Food Allergy and Anaphylaxis ResearchMedicine11.8%
- Contact Dermatitis and AllergiesMedicine5.3%
- Dermatology and Skin DiseasesMedicine5.2%
- Respiratory and Cough-Related ResearchMedicine4%
- Mast cells and histamineImmunology and Microbiology3.6%
- Occupational exposure and asthmaMedicine2.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Allergy | Zone 2 |
| Minor | Immunology | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Allergy | Zone 2 |
| Minor | Immunology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Allergy | Zone 2 |
| Minor | Immunology | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.01LetPub ·
- CiteScore 2026-06
- 8.9LetPub ·
- SJR 2026-06
- 1.35LetPub ·
- SNIP 2026-06
- 1.34LetPub ·
- h-index
- 139LetPub ·
- h-index
- 204OpenAlex ·
- i10-index
- 6,827OpenAlex ·
- 2-year mean citedness
- 2.32OpenAlex ·
- Self-citation rate
- 12%LetPub ·
- Share of gold OA articles
- 57.8%LetPub ·
Volume
- Articles per year
- 72LetPub ·
Articles by year OpenAlex count · 11,245 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 246 | 165 | 81 |
| 2025 | 260 | 192 | 552 |
| 2024 | 186 | 151 | 975 |
| 2023 | 181 | 143 | 1,177 |
| 2022 | 198 | 119 | 2,043 |
| 2021 | 247 | 139 | 4,093 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
88 daysMedian, submission to acceptance · P25–P75 59 days – 131 days
- Acceptance to online
- median 11 days (93 articles)
- Submission to online
- median 102 days
- Sample
- 90 articles with submission and acceptance dates (523 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–8 weeksLetPub ·
- Average acceptance (community reports)
- Fairly hardLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,760 / EUR 4,070 / GBP 3,390 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Monthly
- Founded
- 1989
- ISSN
- 0954-7894
- Electronic ISSN
- 1365-2222
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about CLINICAL AND EXPERIMENTAL ALLERGY
What CAS zone is CLINICAL AND EXPERIMENTAL ALLERGY in?
In the 2025 upgraded edition of the CAS Journal Ranking, CLINICAL AND EXPERIMENTAL ALLERGY is in Zone 2 of Medicine, and in Zone 2 of the minor category Allergy / Immunology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of CLINICAL AND EXPERIMENTAL ALLERGY?
The latest impact factor listed by LetPub is 5.01; CiteScore 8.9, h-index 204.
How long does peer review take at CLINICAL AND EXPERIMENTAL ALLERGY?
Based on the dates recorded on 90 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 88 days (interquartile range 59–131 days); authors report an average review time of 3–8 weeks; the community-reported acceptance is “Fairly hard”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index CLINICAL AND EXPERIMENTAL ALLERGY?
According to LetPub and DOAJ records, CLINICAL AND EXPERIMENTAL ALLERGY is indexed in SCIE and Scopus.
Is CLINICAL AND EXPERIMENTAL ALLERGY open access, and what is the APC?
CLINICAL AND EXPERIMENTAL ALLERGY is a hybrid journal. For open-access publication: APC about USD 4,760.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .